Overview Study to Evaluate the Safety, Pharmacokinetics and Efficacy of STI-2020 (COVI-AMG™) in Outpatients With COVID-19 Status: Withdrawn Trial end date: 2021-04-01 Target enrollment: Participant gender: Summary This is a randomized, placebo-controlled study to assess the safety, PK profile, and efficacy of COVI-AMG in subjects with COVID-19. Phase: Phase 1/Phase 2 Details Lead Sponsor: Sorrento Therapeutics, Inc.